Cheryl Koehn appointed to the CIHR’s Standing Committee on Ethics
The Canadian Institutes of Health has appointed ACE’s Founder and President, Cheryl Koehn, to a three-year term on the Standing Committee on Ethics for the agency. The committee reports to the Governing Council on emerging ethical issues of strategic relevance to health and health research. It provides the Governing Council with high-level strategic advice on the ethical, legal and socio-cultural dimensions of the Canadian Institutes of Health Research’s mandate as set out by federal statute. The committee can act on its own initiative to advise the Governing Council or at the request of the President of the Canadian Institutes of Health Research.
The committee includes the Chief of Bioethics for UNESCO, a representative of industry, seven university faculty, and now a person living with arthritis.
Expressions of Interest: CIHR Institute of Musculoskeletal Health and Arthritis Research Ambassadors
The Institute of Musculoskeletal Health and Arthritis of the Canadian Institutes of Health Research (CIHR – IMHA), is seeking applications to fill four vacancies in the CIHR – IMHA Research Ambassadors group. We specifically need representation from young adults, men, vulnerable populations, and representation of disease groups falling under our research mandate including conditions affecting bone, connective tissue, joint, muscle, oral health and skin.
WHO: Research Ambassadors are members of the public who live with, or advocate for others living with a condition that falls under CIHR – IMHA’s research mandate (conditions related to bones, joints, muscles, connective tissue, skin and teeth). Research Ambassadors bridge the gap between researchers and patients, addressing the different stages of the research process known as: Basic Biomedical Science, Clinical Science and Knowledge, and Clinical Practice and Health Decision Making.
WHAT: The main principles of what Research Ambassadors do are: Continue reading
Researchers, patients and government come together
The conversation on new reform from the Canadian Institutes of Health Research that impacts federal research funding continues.
We commend Minister Philpott for her request for the Canadian Institutes of Health Research (CIHR) to convene a working meeting with key representatives of the research community to find common ground and move forward with solutions that address the issues around the quality and integrity of CIHR’s peer review system.
Minister Philpott’s actions are in response to views expressed within the health research community, and from patient organizations like Arthritis Consumer Experts (ACE).
All stakeholders in healthcare – governments, researchers, clinicians and patients – have an obligation to consider the impact of changes to the CIHR and Canada’s world-class standing in the scientific community and the benefits of health research for all Canadians.
Below is the message from Minister Philpott to Canada’s health research community: Continue reading